Abstract Background In December 2019, a novel coronavirus disease (COVID-19) emerged
in Wuhan, China, with an incredible contagion rate. However, the vertical transmission of …

Background Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak,
there has been an increasing interest in finding a potential therapeutic agent for the disease …

Introduction Patients with immunodeficiency are usually more prone to worse outcomes of
infectious diseases. However, there are some disagreements in the context of COVID-19, for …

Concern regarding coronavirus (CoV) outbreaks has stayed relevant to global health in the
last decades. Emerging COVID-19 infection, caused by the novel SARS-CoV2, is now a …

Purpose Computed tomography (CT) scan is a commonly used tool for the diagnosis of the
novel coronavirus disease 2019 (COVID-19), similarly to reverse transcription-polymerase …

Although presentation of COVID‐19 in patients with immunodeficiency could be mild, it
should not be missed, while early diagnosis and appropriate treatment can survive infected …

The new emerging virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
causes a huge burden of morbidity and mortality worldwide. One of the predisposing factors …

The coronavirus disease 2019 (COVID-19) pandemic has affected almost all countries and
territories. As of December 6, 2020, the United States of America and India have the highest …

COVID-19 can affect the central nervous system (CNS) indirectly by inflammatory
mechanisms and even directly enter the CNS. Thereby, COVID-19 can evoke a range of …

Public health measures associated with coronavirus disease 2019 (COVID-19), such as
lockdowns and quarantine of suspected cases, can negatively affect children's mental health …